GABA Labs Ltd
- Type
- Food & Ingredient Manufacturer
- Location
- Dacorum, United Kingdom
- Industries
- Consumer health & consumer effects, Food ingredients & products, Food reformulation
- Domains
- Ingredients, Functional ingredients, Beverages, Processed food products, Feed
- Technologies
- Biotechnology & sustainable inputs, Artificial intelligence, Smart & digital, Fermentation, Platform technology, Platform & Service technologies
About GABA Labs Ltd
GABA Labs is a UK-based food and beverage ingredient company focused on alcohol alternatives for adult social drinking. It positions itself as a scientific innovator working to create a third option beyond “alcohol or no alcohol” by developing ingredients that aim to deliver conviviality and relaxation without alcohol’s harms.
The company’s messaging centers on a new category of adult drinks powered by its proprietary ingredient concepts, with an emphasis on serving consumers, bars, mixologists, and drinks brands that want better-tasting, more appealing low- or no-alcohol options. GABA Labs says its mission is to deliver better options for adult social drinkers and to help drinks companies create a new generation of alcohol-alternative beverages.
Core Values
- Choice for adult social drinkers: GABA Labs frames its work around expanding consumer choice beyond the binary of alcoholic versus non-alcoholic drinks.
- Healthier alternatives: The company emphasizes reducing alcohol-related harms while preserving the social benefits people seek from drinking.
- Science-led innovation: Its positioning is rooted in research, biomimetic ingredient design, and a regulatory pathway intended to support credible product development.
- Social connection: GABA Labs repeatedly highlights conviviality, relaxation, and the social experience of drinking as central design goals.
Unique Aspects
- A third category of drink: Rather than simply removing alcohol, GABA Labs is trying to create a new adult-drinking category that preserves some desired effects of alcohol.
- Biomimetic ingredient approach: Alcarelle is described as a biomimetic ingredient, meaning it is designed to imitate selected effects associated with alcohol.
- Dual route to market: The company already offers SENTIA as a finished drink range while also developing Alcarelle as a licensable ingredient for other drinks companies.
- Regulatory-first commercialization: GABA Labs says Alcarelle will go through the US FDA GRAS process before being marketed as an ingredient.
- Broad stakeholder engagement: The company actively solicits feedback from consumers, bar owners, ingredients companies, drinks brands, and public health stakeholders as part of its development process.